PAVmed (PAVM) Gains from Investment Securities (2017 - 2019)

PAVmed has reported Gains from Investment Securities for 3 years, with the latest figure at $3.4 million in Q1 2019.

• On a quarterly basis, Gains from Investment Securities rose 3459.76% year-over-year to $3.4 million in Q1 2019; TTM through Jun 2026 was $3.4 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $96480.0, up 104.97% from the prior year.
• Gains from Investment Securities was $3.4 million for Q1 2019 at PAVmed, up from -$150081.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $3.4 million in Q1 2019, with the low at -$2.6 million in Q4 2017.
• Average Gains from Investment Securities over 3 years is $205478.6, with a median of -$150081.0 recorded in 2018.
• The sharpest annual moves came in 2018 and 2019: Gains from Investment Securities surged 79.95% in 2018, then soared 3459.76% in 2019.
• Over 3 years, Gains from Investment Securities stood at -$2.6 million in 2017, then surged by 94.28% to -$150081.0 in 2018, then surged by 2388.4% to $3.4 million in 2019.
• The last three Gains from Investment Securities figures came in at $3.4 million (Q1 2019), -$150081.0 (Q2 2018), and $96480.0 (Q1 2018), per Business Quant data.